Differences in patterns of metabolic abnormality and metabolic syndrome between early-onset and adult-onset first-episode drug-naive schizophrenia patients

被引:11
|
作者
Lang, Xiaoe [1 ]
Zhou, Yang [2 ]
Zhao, Lei [2 ]
Gu, Yinjun [3 ]
Wu, Xi [4 ]
Zhao, Yuefeng [5 ]
Li, Zezhi [6 ]
Zhang, Xiangyang [7 ]
机构
[1] Shanxi Med Univ, Hosp 1, Dept Psychiat, Taiyuan, Peoples R China
[2] Qingdao Univ, Qingdao Mental Hlth Ctr, Qingdao, Peoples R China
[3] Shanghai Jinshan Mental Hlth Ctr, Shanghai, Peoples R China
[4] Shanghai Changhai Hosp, Dept Neurosurg, Shanghai, Peoples R China
[5] Univ Shanghai Sci & Technol, Shanghai, Peoples R China
[6] Guangzhou Med Univ, Affiliated Brain Hosp, Dept Psychiat, 36 Mingxin Rd, Guangzhou 510370, Peoples R China
[7] Chinese Acad Sci, Inst Psychol, CAS Key Lab Mental Hlth, Beijing, Peoples R China
关键词
Early-onset; Adult-onset; Schizophrenia; Metabolic abnormalities; Metabolic syndrome; NEGATIVE SYNDROME SCALE; MAJOR DEPRESSIVE DISORDER; GENOME-WIDE ASSOCIATION; CARDIOVASCULAR RISK; SPECTRUM DISORDERS; BIPOLAR DISORDER; MORTALITY; PANSS; DISTURBANCE; CHILDREN;
D O I
10.1016/j.psyneuen.2021.105344
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Although metabolic abnormalities and metabolic syndrome (MetS) often occur in schizophrenia, few studies have investigated them in early-onset schizophrenia (EOS) patients. To our knowledge, this was the first to compare clinical correlates of metabolic abnormalities between first-episode drug-naive (FEDN) EOS and adultonset schizophrenia (AOS) patients. A total of 489 Chinese FEDN schizophrenia patients (116 EOS and 373 AOS) and 451 healthy controls were recruited in this cross-sectional study. Blood pressure, waist circumference (WC), Body mass index (BMI), total cholesterol (TC), triglycerides (TG), high density lipoprotein cholesterol (HDLC), low density lipoprotein cholesterol (LDLC), glucose, hemoglobin A1c (HbA1c), insulin and insulin resistance were measured. The Positive and Negative Syndrome Scale (PANSS) was applied to evaluate the clinical symptoms of schizophrenia patients, and higher scores on PANSS indicate increased severity. EOS patients had lower rates of: MetS, elevated WC, hypertriglyceridemia, hypercholesterolemia, and hyper-LDLC than EOS patients (all p < 0.05). In EOS patients, WC was positively associated with PANSS general psychopathology score (p = 0.04). In AOS patients, WC (p = 0.01; p = 0.02) and glucose (p < 0.001; p < 0.001) were positively associated with PANSS general psychopathology and total score. HOMA-IR was positively associated with PANSS total score (p = 0.04). Systolic BP, triglycerides and HDLC were main contributors to MetS in AOS (all p < 0.05), but not in EOS. BMI was a risk factor of MetS in EOS, while BMI and HOMA-IR were risk factors of MetS in AOS (all p < 0.05). Our results indicate differences in metabolic abnormalities patterns, risk factors and their association with clinical characteristics between Chinese EOS and AOS patients. Data Availability Statement: The datasets that support the findings of this study are not publically available due to ongoing analyses for further publications, but are available from the corresponding author X.Z. upon reasonable request.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Mitochondrial Dysfunction and Metabolic Indicators in Patients with Drug-Naive First-Episode Schizophrenia: A Case-Control Study
    Chu, Haoran
    Zhu, Houming
    Ma, Jiashu
    Jiang, Yijia
    Cui, Cuicui
    Yan, Xianxia
    Li, Qin
    Zhang, Xinyan
    Chen, Diancai
    Li, Xianwei
    Li, Ranran
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2024, 20 : 2433 - 2442
  • [22] Patterns of drug consumption in first-episode drug-naive schizophrenic patients
    San, L
    Arranz, B
    Ramirez, N
    Dueñas, R
    Sanchez, JM
    Miralles, L
    Berrospi, M
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S416 - S416
  • [23] Comparison of baseline metabolic variables between drug-naive first-episode psychosis patients and healthy controls
    Parrilla, M. A.
    Sengupta, S. M.
    Kin, N. M.
    Klink, R.
    Stip, E.
    Baptista, T.
    Malla, A.
    Joober, R.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 244 - 244
  • [24] Abnormal glucose metabolism is associated with clinical symptoms of adolescent-onset patients with first-episode drug-naive schizophrenia
    Hu, Jinghan
    Zhou, Yongjie
    Wang, Ruoxi
    Qi, Ling
    Zhou, Xin
    Song, Xiuli
    Zeng, Lingyun
    Zhang, Xiangyang
    ASIAN JOURNAL OF PSYCHIATRY, 2021, 62
  • [25] Impaired glucose tolerance in first-episode drug-naive patients with schizophrenia
    Spelman, L. M.
    Walsh, P. I.
    Sharifi, N.
    Collins, P.
    Thakore, J. H.
    DIABETIC MEDICINE, 2007, 24 (05) : 481 - 485
  • [26] Imaging dopamine transmission in drug-naive, first-episode patients with schizophrenia
    Martinez, D
    Kegeles, L
    Printz, D
    Gil, R
    Zea-Ponce, Y
    Mann, J
    Gorman, J
    Laruelle, M
    Abi-Dargham, A
    SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 243 - 244
  • [27] Cerebellar Functional Dysconnectivity in Drug-Naive Patients With First-Episode Schizophrenia
    Cao, Hengyi
    Wei, Xia
    Zhang, Wenjing
    Xiao, Yuan
    Zeng, Jiaxin
    Sweeney, John A.
    Gong, Qiyong
    Lui, Su
    SCHIZOPHRENIA BULLETIN, 2023, 49 (02) : 417 - 427
  • [28] Superior temporal gyrus abnormalities in early-onset schizophrenia: Similarities and differences with adult-onset schizophrenia
    Matsumoto, H
    Simmons, A
    Williams, S
    Hadjulis, M
    Pipe, R
    Murray, R
    Frangou, S
    AMERICAN JOURNAL OF PSYCHIATRY, 2001, 158 (08): : 1299 - 1304
  • [29] The prevalence and clinical correlates of metabolic syndrome and cardiometabolic alterations in 430 drug-naive patients in their first episode of schizophrenia
    Xiaoe Lang
    Qinqin Liu
    Hanliu Fang
    Yongjie Zhou
    Mattew T. Forster
    Zezhi Li
    Xiangyang Zhang
    Psychopharmacology, 2021, 238 : 3643 - 3652
  • [30] The prevalence and clinical correlates of metabolic syndrome and cardiometabolic alterations in 430 drug-naive patients in their first episode of schizophrenia
    Lang, Xiaoe
    Liu, Qinqin
    Fang, Hanliu
    Zhou, Yongjie
    Forster, Mattew T.
    Li, Zezhi
    Zhang, Xiangyang
    PSYCHOPHARMACOLOGY, 2021, 238 (12) : 3643 - 3652